Molecular Pathology Laboratory Network, Inc.'s Chief Medical Officer Dr. Jonathan L. Klein is now also the Medical Director for Tennessee MPLN location. As of June 5th all clinical reports identify Dr.Klein as the Laboratory DIrector.
New guidance, endorsed by ASCO, outlines patient selection criteria for treatment of advanced-stage lung adenocarcinoma or tumors with an adenocarcinoma component with EGFR or ALK inhibitors based on EFGR mutation and ALK rearrangement. The guideline…
Read more
Molecular Pathology Laboratory Network, Inc. (MPLN) acquires the Illumina MiSeqDx™ next generation sequencing system to expand its portfolio of molecular testing and clinical research services to support growing demand in personalized medicine.
…CMS is now requiring two new HCPCS codes be billed when performing immunohistochemistry stains. G0461, for the first antibody stain, and G0462 for each additional stain are the two codes replacing 88342.
MPLN is now billing G-codes (G0461…
Read more
Pathology residents from the University of Tennessee in Knoxville (UT) and the East Tennessee State University (ETSU) Quillen College of Medicine in Johnson City, are familiar sights in the laboratories of MPLN. A partnership began with UT and MPLN…
Read more